Bookmark and Share

BioActivity Data for Compound Benzyl Alcohol (CID 244)

.
BioActivity Outcomes:
Active(9)
 
 
Inactive(461)
 
 
Inconclusive(53)
 
 
Unspecified(160)
 
 
Top Targets:
7tm 4(33)
 
 
 
NR LBD ER(25)
 
 
 
 
NR LBD AR(24)
 
 
 
NR LBD PPAR(23)
 
 
p450(16)
 
 
 
BioAssay Types:
Confirmatory(485)
 
 
 
 
 
Literature(89)
 
 
 
 
 
Summary(63)
 
 
 
Screening(4)
 
 
BioActivity Types:
Potency(382)
 
 
 
 
 
IC50(116)
 
 
EC50(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 458    Data Row: 683   Total Pages: 35   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID17390015]
Potency 5.3582Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
2
[SID17390015]
Potency 6.012Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
3
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_57, Type: Literature]
View
4
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_51, Type: Literature]
View
5
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_43, Type: Literature]
View
6
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_44, Type: Literature]
View
7
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_19, Type: Literature]
View
8
[SID17390015]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature]
View
9
[SID48415620]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
10
[SID103196411]
Km 50Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV) [AID39219, Type: Literature]
View
11
[SID103196411]
Effect on growth in Staphylococcus aureus MN8 at 0.50 % after 24 hrs (Rvb = 100%) [AID555340, Type: Literature]
View
12
[SID103196411]
IC50 DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam) [AID625261, Type: confirmatory]
View
13
[SID103196411]
IC50 DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB) [AID625262, Type: confirmatory]
View
14
[SID103196411]
IC50 DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA) [AID625264, Type: confirmatory]
View
15
[SID103196411]
DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid) [AID625265, Type: other]
View
16
[SID103196411]
IC50 DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653) [AID625266, Type: confirmatory]
View
17
[SID103196411]
IC50 DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP) [AID625267, Type: confirmatory]
View
18
[SID103196411]
IC50 DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630) [AID625219, Type: confirmatory]
View
19
[SID103196411]
IC50 DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) [AID625224, Type: confirmatory]
View
20
[SID103196411]
IC50 DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin) [AID625225, Type: confirmatory]
View